Majority Of Claims In EpiPen Stock-Drop Suit Allowed To Proceed, Judge Rules

Mealey's (April 9, 2020, 2:21 PM EDT) -- NEW YORK — A federal judge in New York on April 6 ruled that lead plaintiffs in a securities class action against drugmaker Mylan N.V. and certain of its current and...
To view the full article, register now.